Clinical Trials for Minerva Biotechnologies

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Minerva Biotechnologies

Clinical Trials (1)

NCT04020575
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
PHASE1Recruiting
69 participants
Started: Jan 15, 2020 · Completed: Jan 15, 2035
1 condition2 sponsors1 location